Tag: Fosun Pharma
-
WHO Approves First Child-Friendly Primaquine to Treat Malaria Relapse
Overview: A historic step in pediatric malaria care The World Health Organization has approved the first-ever child-friendly primaquine tablets for treating malaria relapse in children, marking a significant milestone in the global fight against malaria. This development, backed by collaboration between Medicines for Malaria Venture (MMV) and Fosun Pharma with funding and strategic support from…
-
WHO Approves First Child-Friendly Primaquine Tablets to Fight Malaria Relapses
Groundbreaking approval for pediatric malaria treatment The World Health Organization (WHO) has approved the first-ever child-friendly primaquine tablets designed to treat relapse-causing malaria in children. This milestone, made possible through collaboration between Medicines for Malaria Venture (MMV), Fosun Pharma, and support from Unitaid, marks a significant step toward safer, more effective malaria elimination strategies for…
-
WHO Approves First Child-Friendly Paediatric Primaquine to Tackle Malaria Relapse
Global milestone in malaria elimination The World Health Organization (WHO) has approved the first-ever child-friendly paediatric primaquine tablets, marking a significant advance in the fight against malaria relapse in children. This development promises safer, easier dosing for young patients and strengthens malaria elimination strategies in endemic regions. What makes the new tablets different? Traditionally, primaquine…